Updating earnings guidance

23 Sep

Thank you for joining the PPL conference call on third quarter results as well as our general business outlook.

And as I've indicated in the past, the strength of our growth plan is built on the low risk nature of our business plans and is supported by the strength of our hedging program and our stable stream of utility earnings and cash flows. Today, we announced third quarter 2017 reported earnings of

In a statement, Lisa Su, CEO at AMD, had the following to offer...

As mentioned above, Advanced Micro Devices is having an incredibly strong start in the pre-market hours this morning after reporting earnings.

Of course, the report proved to be overwhelmingly positive. In a statement, AMD said that its revenue came in strong due to strong sales in the computing and graphics segment.

"While investors could view this quarter's performance as less compelling than that of recent quarters, we do think BSX absorbed some weather-related headwinds, delivering a sales beat and in-line EPS despite this," wrote Leerink Partners' Danielle Antalffy in a note Thursday.

New York-based Bristol-Myers lowered its 2017 GAAP EPS guidance range to .36 to .46, compared with previous guidance of .66 to .76.

.51 per share compared with

Thank you for joining the PPL conference call on third quarter results as well as our general business outlook.And as I've indicated in the past, the strength of our growth plan is built on the low risk nature of our business plans and is supported by the strength of our hedging program and our stable stream of utility earnings and cash flows. Today, we announced third quarter 2017 reported earnings of

In a statement, Lisa Su, CEO at AMD, had the following to offer...

As mentioned above, Advanced Micro Devices is having an incredibly strong start in the pre-market hours this morning after reporting earnings.

Of course, the report proved to be overwhelmingly positive. In a statement, AMD said that its revenue came in strong due to strong sales in the computing and graphics segment.

"While investors could view this quarter's performance as less compelling than that of recent quarters, we do think BSX absorbed some weather-related headwinds, delivering a sales beat and in-line EPS despite this," wrote Leerink Partners' Danielle Antalffy in a note Thursday.

New York-based Bristol-Myers lowered its 2017 GAAP EPS guidance range to .36 to .46, compared with previous guidance of .66 to .76.

.51 per share compared with [[

Thank you for joining the PPL conference call on third quarter results as well as our general business outlook.And as I've indicated in the past, the strength of our growth plan is built on the low risk nature of our business plans and is supported by the strength of our hedging program and our stable stream of utility earnings and cash flows. Today, we announced third quarter 2017 reported earnings of $0.51 per share compared with $0.69 per share a year ago. For reconciliations to the GAAP measure, you should refer to the press release, which has been posted on our website and furnished to the SEC. We're in the process of updating our business plans now and we will provide earnings guidance for 2018 and an update to our longer-term growth rate on the year-end call. We will refer to earnings from ongoing operations or ongoing earnings, a non-GAAP measure, on this call. We continue to expect 5% to 6% compound annual earnings per share growth from 2017 through 2020, measured against the original 2017 ongoing earnings forecast midpoint of $2.15 per share.Of course, this led to excitement among investors, causing gains and prompting an alert from our partners at Trade Ideas.At the moment (), AMD is trading at $15.33 per share after a gain of $1.22 per share or 8.65% thus far today.

||

Thank you for joining the PPL conference call on third quarter results as well as our general business outlook.

And as I've indicated in the past, the strength of our growth plan is built on the low risk nature of our business plans and is supported by the strength of our hedging program and our stable stream of utility earnings and cash flows. Today, we announced third quarter 2017 reported earnings of $0.51 per share compared with $0.69 per share a year ago.

]].69 per share a year ago. For reconciliations to the GAAP measure, you should refer to the press release, which has been posted on our website and furnished to the SEC. We're in the process of updating our business plans now and we will provide earnings guidance for 2018 and an update to our longer-term growth rate on the year-end call. We will refer to earnings from ongoing operations or ongoing earnings, a non-GAAP measure, on this call. We continue to expect 5% to 6% compound annual earnings per share growth from 2017 through 2020, measured against the original 2017 ongoing earnings forecast midpoint of .15 per share.Of course, this led to excitement among investors, causing gains and prompting an alert from our partners at Trade Ideas.At the moment (), AMD is trading at .33 per share after a gain of

Thank you for joining the PPL conference call on third quarter results as well as our general business outlook.And as I've indicated in the past, the strength of our growth plan is built on the low risk nature of our business plans and is supported by the strength of our hedging program and our stable stream of utility earnings and cash flows. Today, we announced third quarter 2017 reported earnings of $0.51 per share compared with $0.69 per share a year ago. For reconciliations to the GAAP measure, you should refer to the press release, which has been posted on our website and furnished to the SEC. We're in the process of updating our business plans now and we will provide earnings guidance for 2018 and an update to our longer-term growth rate on the year-end call. We will refer to earnings from ongoing operations or ongoing earnings, a non-GAAP measure, on this call. We continue to expect 5% to 6% compound annual earnings per share growth from 2017 through 2020, measured against the original 2017 ongoing earnings forecast midpoint of $2.15 per share.Of course, this led to excitement among investors, causing gains and prompting an alert from our partners at Trade Ideas.At the moment (), AMD is trading at $15.33 per share after a gain of $1.22 per share or 8.65% thus far today.

||

Thank you for joining the PPL conference call on third quarter results as well as our general business outlook.

And as I've indicated in the past, the strength of our growth plan is built on the low risk nature of our business plans and is supported by the strength of our hedging program and our stable stream of utility earnings and cash flows. Today, we announced third quarter 2017 reported earnings of $0.51 per share compared with $0.69 per share a year ago.

.22 per share or 8.65% thus far today.

.69 per share a year ago.

[[

In a statement, Lisa Su, CEO at AMD, had the following to offer...

As mentioned above, Advanced Micro Devices is having an incredibly strong start in the pre-market hours this morning after reporting earnings.

Of course, the report proved to be overwhelmingly positive. In a statement, AMD said that its revenue came in strong due to strong sales in the computing and graphics segment.

"While investors could view this quarter's performance as less compelling than that of recent quarters, we do think BSX absorbed some weather-related headwinds, delivering a sales beat and in-line EPS despite this," wrote Leerink Partners' Danielle Antalffy in a note Thursday.

New York-based Bristol-Myers lowered its 2017 GAAP EPS guidance range to $2.36 to $2.46, compared with previous guidance of $2.66 to $2.76.

||

In a statement, Lisa Su, CEO at AMD, had the following to offer...As mentioned above, Advanced Micro Devices is having an incredibly strong start in the pre-market hours this morning after reporting earnings.Of course, the report proved to be overwhelmingly positive. In a statement, AMD said that its revenue came in strong due to strong sales in the computing and graphics segment."While investors could view this quarter's performance as less compelling than that of recent quarters, we do think BSX absorbed some weather-related headwinds, delivering a sales beat and in-line EPS despite this," wrote Leerink Partners' Danielle Antalffy in a note Thursday.New York-based Bristol-Myers lowered its 2017 GAAP EPS guidance range to $2.36 to $2.46, compared with previous guidance of $2.66 to $2.76.

]]